2
and the other solvents were distilled from CaH2. Merck silica gel
60GF254 was used for the preparative thin-layer chromatography.
Ar-F), −114.9 (d, JF, F = 292.0 Hz, 2 F, CF2CF3), −116.1 (d,
2JF, F = 292.0 Hz, 4 F, CF2CF3), −118.5 (dm, JF, F = 292.0 Hz,
2
2 F, CF2CF3) ppm. 31P NMR (162 MHz, CDCl3): d −11.1 ppm.
Anal. Found: C, 41.48; H, 1.18. Calc. for C28H12F21O2P: C, 41.50;
H, 1.49%.
General procedure for the synthesis of O-equatorial
arylphosphoranes
Synthesis of 12d. Following the above-described procedure
using p-bromoanisole (d = 1.494 g mL−1, 0.060 mL, 0.48 mmol)
and 14 (62.5 mg, 0.0872 mmol), 12d (34.7 mg, 0.0421 mmol,
48%) was isolated as a white solid. Colorless crystals of 12d
suitable for the X-ray analysis were obtained by recrystallization
from n-hexane–CH2Cl2. Mp 124.0–125.0 ◦C (decomp.). 1H NMR
(400 MHz, CDCl3): d 7.96–8.03 (m, 2 H, Ar–H), 7.76 (br s, 2
H, Ar–H), 7.58–7.61 (m, 4 H, Ar–H), 7.50 (dd, 3JH, P = 15.0 Hz,
3JH, H = 8.8 Hz, 2 H, Ar–H), 6.78 (d, 4JH, P = 7.8 Hz, 3JH, H = 8.8 Hz,
2 H, Ar–H), 3.74 (s, 3 H, Ar-OCH3) ppm. 19F NMR (376 MHz,
Synthesis of 12a. PhLi (1.14 M cyclohexane–Et2O solution,
0.19 mL, 0.216 mmol) was added to a solution of P–H phospho-
rane 14 (49.9 mg, 0.0696 mmol) in Et2O (3.0 mL) at −78 ◦C. The
mixture was then stirred for 1 h at room temperature. I2 (52.0 mg,
0.204 mmol) was added to the mixture at −78 ◦C, and the mixture
was stirred for 1 h at 0 ◦C. The reaction was then quenched
with aqueous Na2S2O3 (30 mL). The mixture was extracted with
Et2O (2 × 40 mL), and the organic layer was washed with brine
(2 × 40 mL) and dried over anhydrous MgSO4. After removing
the solvents by evaporation, the resulting crude product was
separated by preparative TLC (n-hexane–CH2Cl2 = 7 : 1) to afford
12a (47.0 mg, 0.0593 mmol, 85%) as a white solid. Colorless
crystals of 12a suitable for the X-ray analysis were obtained
by recrystallization from n-hexane–CH2Cl2. Mp 115.0–116.0 ◦C
(decomp.). 1H NMR (400 MHz, CDCl3): d = 7.95–7.99 (m, 2 H,
Ar–H), 7.74 (br s, 2 H, Ar–H), 7.59–7.62 (m, 4 H, Ar–H), 7.49–
7.55 (m, 2 H, Ar–H), 7.24–7.28 (m, 3 H, Ar–H) ppm. 19F NMR
3
CDCl3): d −78.8 (s, 6 F, CF2CF3), −79.4 (dd, JF, F = 9.8 Hz,
2
5JF, F = 9.8 Hz, 6 F, CF2CF3), −115.0 (d, JF, F = 292.0 Hz, 2 F,
2
CF2CF3), −116.2 (br d, JF, F = 292.0 Hz, 4 F, CF2CF3), −118.5
(dm, 2JF, F = 292.0 Hz, 2 F, CF2CF3) ppm. 31P NMR (162 MHz,
CDCl3): d −10.7 ppm. Anal. Found: C, 42.05; H, 1.60. Calc. for
C29H15F20O3P: C, 42.35; H, 1.84%.
Synthesis of 12e. Following the above-described procedure
using 2-bromomesitylene (d = 1.301 g mL−1, 0.10 mL, 0.65 mmol)
and 14 (71.3 mg, 0.0995 mmol), 12e (69.2 mg, 0.0829 mmol, 83%)
was isolated as a white solid. Colorless crystals of 12e suitable
for the X-ray analysis were obtained by recrystallization from
(376 MHz, CDCl3): d −78.8 (s, 6 F, CF2CF3), −79.4 (dd, 3JF, F
=
9.8 Hz, 5JF, F = 9.8 Hz, 6 F, CF2CF3), −114.8 (d, 2JF, F = 295.6 Hz,
2 F, CF2CF3), −116.1 (d, 2JF, F = 295.6 Hz, 4 F, CF2CF3), −118.4
(dm, 2JF, F = 295.6 Hz, 2 F, CF2CF3) ppm. 31P NMR (162 MHz,
CDCl3): d −10.6 ppm. Anal. Found: C, 42.43; H, 1.26. Calc. for
C28H13F20O2P: C, 42.44; H, 1.65%.
◦
1
CH3CN. Mp 113.1–113.9 C. H NMR (400 MHz, CDCl3): d
7.95–7.98 (m, 1 H, Ar–H), 7.81 (br d, 3JH, H = 8.0 Hz, 1 H, Ar–H),
3
4
7.69 (td, JH, H = 8.0 Hz, JH, H = 1.2 Hz, 1 H, Ar–H), 7.61 (br
Synthesis of 12b. Following the above-described procedure
using p-bromobenzotrifluoride (d = 1.607 g mL−1, 0.040 mL,
0.29 mmol) and 14 (51.8 mg, 0.0723 mmol), 12b (36.0 mg,
0.0418 mmol, 58%) was isolated as a white solid. Colorless
crystals of 12b suitable for the X-ray analysis were obtained
by recrystallization from n-hexane–CH2Cl2. Mp 106.0–107.0 ◦C
3
d, JH, H = 8.0 Hz, 1 H, Ar–H), 7.44–7.53 (m, 4 H, Ar–H), 6.81
4
4
(d, JH, P = 4.4 Hz, 1 H, Ar–H), 6.73 (d, JH, P = 8.3 Hz, 1 H,
Ar–H), 2.65 (s, 3 H, Ar–CH3), 2.27 (s, 3 H, Ar–CH3), 2.18 (s, 3
H, Ar–CH3) ppm. 19F NMR (376 MHz, CDCl3): d −78.1 (s, 3 F,
CF2CF3), −78.4 (s, 3 F, CF2CF3), −79.1 (s, 3 F, CF2CF3), −79.2 (s,
3 F, CF2CF3), −112.9 (d, 2JF, F = 292.0 Hz, 1 F, CF2CF3), −113.8
(d, 2JF, F = 292.0 Hz, 1 F, CF2CF3), −114.1 (d, 2JF, F = 292.0 Hz,
2 F, CF2CF3), −114.9 (d, 2JF, F = 292.0 Hz, 1 F, CF2CF3), −115.3
(d, 2JF, F = 292.0 Hz, 1 F, CF2CF3), −115.7 (d, 2JF, F = 292.0 Hz, 1
1
(decomp.). H NMR (400 MHz, CDCl3): d 7.92–7.96 (m, 2 H,
Ar–H), 7.76 (br s, 2 H, Ar–H), 7.62–7.66 (m, 4 H, Ar–H), 7.61
(dd, 3JH, P = 15.0 Hz, 3JH, H = 8.3 Hz, 2 H, Ar–H), 7.53 (d, 4JH, P
=
3
7.8 Hz, JH, H = 8.3 Hz, 2 H, Ar–H) ppm. 19F NMR (376 MHz,
F, CF2CF3), −117.8 (d, 2JF, F = 292.0 Hz, 1 F, CF2CF3) ppm. 31
P
CDCl3): d −63.5 (s, 3 F, Ar–CF3), −78.8 (s, 6 F, CF2CF3), −79.5
NMR (162 MHz, CDCl3): d −2.7 ppm. Anal. Found: C, 44.54; H,
(dd, 3JF, F = 9.8 Hz, 5JF, F = 9.8 Hz, 6 F, CF2CF3), −114.8 (d, 2JF, F
=
2.07. Calc. for C31H19F20O2P: C, 44.62; H, 2.30%.
2
292.0 Hz, 2 F, CF2CF3), −116.2 (br dm, JF, F = 292.0 Hz, 4 F,
2
CF2CF3), −118.4 (dm, JF, F = 292.0 Hz, 2 F, CF2CF3) ppm. 31P
Synthesis of 13a. A solution of 12a (12.2 mg, 0.0153 mmol) in
C6D6 (1.0 mL) was heated at 80 ◦C for 8 h. After concentration in
vacuo, 13a was obtained (12.0 mg, 0.0151 mmol, 98%) as a white
solid. Mp 149.1–150.0 ◦C. 1H NMR (400 MHz, CDCl3): d 8.70–
NMR (162 MHz, CDCl3): d −11.4 ppm. Anal. Found: C, 40.19;
H, 1.01. Calc. for C29H12F23O2P: C, 40.49; H, 1.41%.
Synthesis of 12c. Following the above-described procedure
using p-bromofluorobenzene (d = 1.593 g mL−1, 0.040 mL,
0.36 mmol) and 14 (47.7 mg, 0.0665 mmol), 12c (41.2 mg,
0.0508 mmol, 76%) was isolated as a white solid. Colorless
crystals of 12c suitable for the X-ray analysis were obtained
by recrystallization from n-hexane–CH2Cl2. Mp 112.5–113.5 ◦C
8.78 (m, 2 H, Ar–H), 7.69–7.82 (m, 6 H, Ar–H), 7.41 (dd, 3JH, P
=
3
15.8 Hz, JH, H = 8.0 Hz, 2 H, Ar–H), 7.18–7.27 (m, 3 H, Ar–
H) ppm. 19F NMR (376 MHz, CDCl3): d −78.3 (s, 6 F, CF2CF3),
−79.8 (dd, 3JF, F = 19.7 Hz, 5JF, F = 6.2 Hz, 6 F, CF2CF3), −116.7
2
(s, 2 F, CF2CF3), −116.8 (s, 2 F, CF2CF3), −116.8 (dq, JF, F
=
=
3
2
285.8 Hz, JF, F = 19.7 Hz, 2 F, CF2CF3), −121.9 (dq, JF, F
1
(decomp.). H NMR (400 MHz, CDCl3): d 7.93–7.98 (m, 2 H,
285.8 Hz, 5JF, F = 6.2 Hz, 2 F, CF2CF3) ppm. 31P NMR (162 MHz,
CDCl3): d −26.9 ppm. Anal. Found: C, 42.30; H, 1.64. Calc. for
C28H13F20O2P: C, 42.44; H, 1.65%.
3
Ar–H), 7.76 (br d, JH, H = 8.0 Hz, 2 H, Ar–H), 7.61–7.64 (m, 4
3
3
4
H, Ar–H), 7.54 (ddd, JH, P = 15.0 Hz, JH, H = 9.0 Hz, JH, F
=
3
3
6.0 Hz, 2 H, Ar–H), 6.96 (ddd, JH, F = 9.0 Hz, JH, H = 9.0 Hz,
4JH, P = 3.6 Hz, 2 H, Ar–H) ppm. 19F NMR (376 MHz, CDCl3): d
−78.8 (s, 6 F, CF2CF3), −79.5 (dd, 3JF, F = 9.8 Hz, 5JF, F = 9.8 Hz,
Synthesis of 13b. A solution of 12b (14.0 mg, 0.0162 mmol) in
◦
C6D6 (1.0 mL) was heated at 80 C for 8 h. After concentration
3
4
6 F, CF2CF3), −111.0 (tt, JH, F = 9.0 Hz, JH, F = 6.0 Hz, 1 F,
3684 | Dalton Trans., 2008, 3678–3687
in vacuo, 13b was obtained (13.5 mg, 0.0157 mmol, 96%) as a
This journal is
The Royal Society of Chemistry 2008
©